Developed by clinicians and medical informatics experts, TheraDoc’s clinical surveillance system helps providers monitor and protect patients from infections, harmful drug interactions and other adverse events. It offers secure, scalable solutions and expertise to improve antimicrobial stewardship, patient safety and care coordination, as well as reduce healthcare-associated infections (HAIs) and adhere to NHSN reporting. A real-time IT engine, TheraDoc integrates clinical data to:
- Create clinically relevant, actionable information
- Apply evidence-based clinical knowledge
- Standardize workflow and communication
Preventing patient harm due to adverse drug events (ADEs) is a top-of-mind priority for the healthcare community, as the World Health Organization found that at least 2 million people contract antibiotic-resistant infections each year. DSS TheraDoc Adverse Drug Events Assistant integrates with primary and ancillary healthcare information systems to deliver real-time clinical decision support at the point of care. Leveraging patient information, coded clinical data, global medical knowledge, institutional protocols and epidemiological statistics, our solution enables hospitals and medical facilities to prevent, identify, treat and report ADEs in a timely and cost-effective manner.
Contact DSS today at 561-284-7000 or e-mail email@example.com to request more information about TheraDoc.
In addition to providing a comprehensive overview of antimicrobial resistance (AR) and the VHA’s initiative, download this white paper will review the directive’s recommended best practices, as well as identify the informatics software solutions that can best be leveraged to help VA medical facilities comply with the mandate and combat the spread of antimicrobial resistance.
 “Antibiotic Resistance Threats in the United States, 2013.” U.S. Department of Health and Human Services Centers for Disease Control and Prevention. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf